TipRanks
Kwang Dong Pharmaceutical Co., Ltd. (KR:009290)
:009290
South Korea Market
009290
Kwang Dong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Kwang Dong Pharmaceutical Co., Ltd. (009290) Income Statement

― Followers

Kwang Dong Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2026), Kwang Dong Pharmaceutical Co., Ltd.'s total revenue was ₩439.82B, an increase of 3.42% from the same quarter last year. In Q2, Kwang Dong Pharmaceutical Co., Ltd.'s net income was ₩2.71B. See Kwang Dong Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 1.66T₩ 1.64T₩ 1.51T₩ 1.43T₩ 1.34T
Gross Profit
₩ 293.22B₩ 299.30B₩ 295.12B₩ 282.05B₩ 274.25B
Operating Expenses
₩ 262.17B₩ 269.20B₩ 249.12B₩ 243.80B₩ 229.32B
Depreciation and Amortization
₩ 17.49B₩ 14.53B₩ 12.90B₩ 13.95B₩ 14.04B
EBITDA
₩ 48.54B₩ 44.63B₩ 54.97B₩ 53.97B₩ 51.02B
Operating Income
₩ 31.05B₩ 30.10B₩ 48.77B₩ 38.24B₩ 44.94B
Other Income/Expenses
₩ -60.97M₩ 27.23B₩ 251.69M₩ -1.95B₩ -10.61B
Pretax Income
₩ 30.98B₩ 57.32B₩ 49.02B₩ 36.29B₩ 34.33B
Net Income
₩ 20.97B₩ 40.48B₩ 36.97B₩ 24.17B₩ 24.02B
Per Share Metrics
Basic EPS
₩ 521.00₩ 1.01K₩ 913.39₩ 588.45₩ 584.68
Diluted EPS
₩ 521.00₩ 1.01K₩ 913.39₩ 588.45₩ 584.33
Weighted Average Shares Outstanding
 52.42M 40.03M 40.47M 41.08M 41.08M
Weighted Average Shares Outstanding (Diluted)
 52.42M 40.03M 40.47M 41.08M 41.13M
Currency in KRW

Kwang Dong Pharmaceutical Co., Ltd. Earnings and Revenue History